Showing results (191-200 of 241) with videos related to
Sort By:
Pageof 25
The World Allergy Organization Journal|November 12, 2019
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testingS Zielen, P Kuna, W Aberer, et al.Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|April 20, 2005
A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopiaJonathan M Holmes, Allison R Edwards, Roy W Beck, et al.Ophthalmology|November 1, 2008
Instability of ocular alignment in childhood esotropia, Stephen P Christiansen, Danielle L Chandler, et al.Allergy|November 20, 2014
Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxisK Brockow, S Schallmayer, K Beyer, et al.Allergy|September 24, 2017
National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE-IID E S Larenas-Linnemann, D Antolín-Amérigo, C Parisi, et al.Allergy|August 29, 1998
Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergensB R Balda, H Wolf, C Baumgarten, et al.Allergy|November 25, 2017
Perspectives in allergen immunotherapy: 2017 and beyondO Pfaar, S Bonini, V Cardona, et al.Journal of Investigational Allergology & Clinical Immunology|May 6, 2022
Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of NumbersS Becker, F Fassio, R Muñoz-Cano, et al.Allergy|October 26, 2017
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsI Kortekaas Krohn, M M Shikhagaie, K Golebski, et al.Pageof 25